Its clinical features and immunopathological mechanisms are distinct from both classic multiple sclerosis (MS) and aquaporin-4 (AQP4)-IgG-positive NMOSD, and being considered as a disease entity in its own, i.e. MOG antibody-associated disease (MOGAD) (3, 4). Here, AQP4 is linked to myeloid sarcoma.